Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src
-
Published:2024-02-12
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Li ZhenxiORCID, Yang Xinghai, Fu Ruifeng, Wu Zhipeng, Xu Shengzhao, Jiao Jian, Qian Ming, Zhang Long, Wu Chunbiao, Xie Tianying, Yao Jiqiang, Wu Zhixiang, Li Wenjun, Ma Guoli, You YuORCID, Chen YihuaORCID, Zhang Han-kun, Cheng Yiyun, Tang XiaolongORCID, Wu PengfeiORCID, Lian Gewei, Wei Haifeng, Zhao Jian, Xu JianrongORCID, Ai Lianzhong, Siwko Stefan, Wang Yue, Ding Jin, Song GaojieORCID, Luo JianORCID, Liu MingyaoORCID, Xiao Jianru
Abstract
AbstractOsteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Rachner, T. D., Khosla, S. & Hofbauer, L. C. Osteoporosis: now and the future. Lancet 377, 1276–1287 (2011). 2. Raisz, L. G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115, 3318–3325 (2005). 3. Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003). 4. Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J. M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17–25 (2006). 5. Miyazaki, T. et al. Src kinase activity is essential for osteoclast function. J. Biol. Chem. 279, 17660–17666 (2004).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|